YOLFTbeta
Metro Healthcare Indonesia

Metro Healthcare Indonesia

CARE · JK · Healthcare / Medical Care Facilities

356.00IDR+18.00 (+5.33%)

Price History

Full chart

Market Stats

Previous Close338.00
Open338.00
Day Range338.00 – 364.00
52-Week Range290.00 – 965.00
Volume331.70K
Market Cap12.37T
P/E (TTM)1957.89
Forward P/E0.00
EPS0.19
Dividend Yield0.00%
Beta-0.44
50-Day Avg416.00
200-Day Avg468.11

About

PT Metro Healthcare Indonesia Tbk owns, operates, and manages hospitals in Indonesia. It provides healthcare activities and physical treatment, outpatient, inpatient managed by private hospitals; manages business consulting and activities, sells laboratory equipment, pharmaceuticals, and medical devices; undertakes hospital activities, and retail trade of pharmaceutical products at pharmacies. It also offers management consulting services; and operates private polyclinics. The company was founded in 2015 and is based in Tangerang, Indonesia.

Company Details

  • SectorHealthcare
  • IndustryMedical Care Facilities
  • CEOEngineer Henry Kembaren M.M.
  • Employees866
  • HeadquartersJl. Raya Serang Km 16,8, Tangerang, Indonesia, 15710, Indonesia
  • Websitehttps://www.metrohealthcareindonesia.co.id

Leadership

  • Engineer Henry Kembaren M.M.President Director · b. 1958
  • Dedi A.Finance & Accounting Manager
  • . EvelinaHRD Manager
  • Irene OctaviaHead of Internal Audit Unit · b. 1986
  • Dr. Dedi TedjakusnadiCorporate Secretary & Director · b. 1958
  • Debby SandraHRD Staff · b. 1997

Financials

Income Statement

Currency: IDR2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue031.20B87.21B154.08B216.30B290.93B260.43B242.68B319.02B439.75B
Growth (%)--+179.53%+76.68%+40.38%+34.51%-10.49%-6.81%+31.46%+37.84%
Cost of Revenue016.33B49.55B78.41B113.40B145.00B164.19B153.03B214.43B224.59B
Gross Profit014.86B37.66B75.66B102.89B145.93B96.23B89.65B104.59B215.16B
Gross Margin-47.65%43.18%49.11%47.57%50.16%36.95%36.94%32.78%48.93%
Operating Expense175.00M14.02B41.14B66.99B118.41B131.84B156.82B125.79B134.52B144.64B
Operating Income-175.00M847.44M-3.48B8.67B-15.52B14.10B-60.59B-36.14B-29.93B70.52B
Operating Margin-2.72%-3.99%5.63%-7.17%4.85%-23.27%-14.89%-9.38%16.04%
EBITDA7.06B4.78B4.21B5.84B37.22B31.94B19.71B-8.76B27.07B96.84B
EBITDA Margin-15.33%4.82%3.79%17.21%10.98%7.57%-3.61%8.48%22.02%
Net Income10.42B-11.52B-27.49B-24.21B14.31B6.10B-93.54B-110.92B-80.31B4.95B
Net Income Margin--36.92%-31.52%-15.71%6.62%2.10%-35.92%-45.71%-25.17%1.13%
Interest Expense013.56B23.17B19.25B11.31B25.84B90.15B76.86B77.32B80.36B
Interest Expense % of Total Revenue-43.46%26.57%12.49%5.23%8.88%34.61%31.67%24.23%18.27%

Balance Sheet

Currency: IDR2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets221.47B328.02B552.01B2.45T3.45T4.21T4.23T4.14T4.02T4.18T
Total Liabilities210.85B316.69B579.15B175.33B154.91B912.94B1.03T1.04T1.00T1.15T
Total Equity10.67B-1.01B-28.24B2.27T3.29T3.30T3.21T3.10T3.02T3.02T
Cash2.81B11.30B7.94B6.95B525.48B542.40B533.21B525.76B449.07B420.24B
Total Debt70.80B92.18B141.88B132.72B116.16B844.06B957.04B954.51B944.47B833.93B
Net Debt67.99B80.88B133.94B125.78B-409.32B301.66B423.83B428.75B495.40B413.69B

Cash Flow

Currency: IDR2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-1.10M-17.10B-29.03B-22.98B50.30B47.13B-93.60B-83.03B-113.01B45.89B
Investing Cash Flow-6.64B-41.38B-225.98B-681.05B-502.27B-760.31B39.83B78.51B42.53B-218.21B
Financing Cash Flow9.20B66.97B251.64B703.05B970.50B727.45B249.41M-2.92B-6.21B143.45B
Capital Expenditure4.33B48.81B215.10B363.31B522.27B310.40B290.45B12.56B226.93B210.76B
Free Cash Flow-1.10M-65.91B-244.13B-386.29B-471.97B-263.28B-384.06B-95.60B-339.94B-164.87B
FCF to OCF100.00%385.38%841.08%1681.22%-938.25%-558.63%410.30%115.13%300.80%-359.30%

Earnings

Report DateMar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020May 31, 2021Sep 1, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Aug 31, 2022Dec 1, 2022Mar 31, 2023May 5, 2023Jul 31, 2023
EPS Estimate--------------
EPS Actual-0.020.210.140.100.290.180.09-0.38-0.65-0.91-0.85-0.41-0.97-0.24
Surprise--------------
Timing---------After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours

Key Statistics & Ratios

Market Cap12.37T
Enterprise Value13.63T
Trailing P/E1957.89
Forward P/E0.00
Price / Sales25.08
Price / Book4.31
EPS0.19
Book Value90.96
Revenue (TTM)493.13B
Gross Profit (TTM)243.95B
EBITDA120.33B
Profit Margin1.22%
Operating Margin30.00%
Return on Equity0.21%
Return on Assets1.45%
Shares Outstanding33.25B
Shares Float16.65B
Beta-0.44
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%